Regenxbio looks to partner neurodegenerative gene therapy work, lays off 15% of staff
Regenxbio has laid off 15% of its staff as it narrows down its pipeline to focus on three gene therapy programs.
The Rockville, MD-based biotech …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
